Grants and Contributions:
Title:
Advancing Noa Therapeutics' lead drug candidate
Agreement Number:
1018597
Agreement Value:
$75,000.00
Agreement Date:
May 1, 2024 - Feb 3, 2025
Description:
Research to advance Noa Therapeutics' lead drug candidate.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Toronto, Ontario, CA M5G 1L7
Reference Number:
172-2024-2025-Q1-1018597
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
714319308
Recipient Type:
For-profit organization
Recipient's Operating Name:
Noa Therapeutics
Recipient's Legal Name:
Noa Therapeutics Inc.
Federal Riding Name:
University--Rosedale
Federal Riding Number:
35110
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
54171